Clinical and diagnostic aspects of tonsillitis-associated arthritis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To identify clinical and diagnostic features of tonsillitis-associated arthritis.

Material and methods. In total, 150 patients were examined (97 women, 53 men, average age 27.6 years). Patients were divided into 2 groups of 75 people. Group 1 consisted of patients with chronic tonsillitis and arthralgia, group 2 – of patients with chronic tonsillitis without arthralgia. The examination included filling out a questionnaire, examination by an otolaryngologist, and laboratory testing consisting of measurements of C-reactive protein, rheumatoid factor, antistreptolysin O (ASO), antinuclear antibodies (ANA) in НЕр-2 cell line, antibodies against cyclic citrullinated peptide, vitamin D, antibodies against capsid and nuclear antigens of the Epstein–Barr virus (IgG). If necessary, patients were referred to a rheumatologist for consultation.

Results. Patients in group 1 were 2.3 times more likely to have a history of tonsillitis and peritonsillar abscesses (82 % versus 36 %). Most of the patients in group 1 had ASO levels above the reference values (37 % versus 19 %; p ≤0.05). Almost 1 / 3 (35 %) of the patients in group 1 had elevated antinuclear antibody titers compared to 11 % in the control group. In group 1, examination revealed 60 patients (80 %) with reactive arthralgia, 8 patients (11 %) with poststreptococcal reactive arthritis, and 7 patients (9 %) with systemic diseases of the connective tissues.

Conclusion. In the etiology of tonsillitis-associated arthritis, frequent episodes of acute tonsillitis have clinical and diagnostic value. According to certain laboratory parameters, such as ASO, ANA, etc., there are statistically significant differences in patients with tonsillitis-associated arthritis. Among patients with chronic tonsillitis and articular syndrome, the frequency of reactive arthralgia significantly prevails over “true” arthritis with signs of joint inflammation.

 

About the authors

A. I. Kryukov

L.I. Sverzhevsky Research Clinical Institute of Otolaryngology, Moscow Healthcare Department; N.I. Pirogov Russian National Research Medical University (Pirogov University), Ministry of Health of Russia

Email: srhinologist@gmail.com
ORCID iD: 0000-0002-0149-0676
Russian Federation, Build. 2, 18A Zagorodnoye Shosse, Moscow 117152; 1 Ostrovityanova St., Moscow 117513

A. A. Klimenko

N.I. Pirogov Russian National Research Medical University (Pirogov University), Ministry of Health of Russia

Email: srhinologist@gmail.com
ORCID iD: 0000-0002-7410-9784
Russian Federation, 1 Ostrovityanova St., Moscow 117513

A. S. Tovmasyan

L.I. Sverzhevsky Research Clinical Institute of Otolaryngology, Moscow Healthcare Department

Email: srhinologist@gmail.com
ORCID iD: 0000-0002-1214-4939
Russian Federation, Build. 2, 18A Zagorodnoye Shosse, Moscow 117152

S. R. Ramazanov

N.I. Pirogov Russian National Research Medical University (Pirogov University), Ministry of Health of Russia

Author for correspondence.
Email: srhinologist@gmail.com
ORCID iD: 0000-0001-5122-7270
SPIN-code: 4779-4411
Russian Federation, 1 Ostrovityanova St., Moscow 117513

References

  1. Haidara A., Sidibe Y., Samake D. et al. Tonsillitis and their complications: epidemiological, clinical and therapeutic profiles. Int J Otorhinolaryngol Head Neck Surg 2019;8(3):98–105. doi: 10.4236/ijohns.2019.83011
  2. Palchun V.T., Kryukov A.I., Gurov A.V. et al. Palatine tonsils: physiology and pathology. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology 2019;84(6):11–6. (In Russ.). doi: 10.17116/otorino20198406111
  3. Ananyeva L.P. The role of autoantibodies in the early diagnosis of systemic immune-inflammatory rheumatic diseases. Sovremennaya revmatologiya = Modern Rheumatology Journal 2019;13(1):5–10. (In Russ.). doi: 10.14412/1996-7012-2019-1-5-10
  4. Aleksandrova E.N., Novikov A.A., Nasonov E.L. Modern standards for laboratory diagnostics of rheumatic diseases and their use in real clinical practice. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice 2013;51(4):368–76. (In Russ.). doi: 10.14412/1995-4484-2013-1251
  5. Galushko E.A., Nasonov E.L. Prevalence of rheumatic diseases in Russia. Al’manakh klinicheskoy meditsiny = Almanac of Clinical Medicine 2018;46(1):32–9. (In Russ.). doi: 10.18786/2072-0505-2018-46-1-32-39
  6. Aletaha D., Neogi T., Silman A.J. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569–81. doi: 10.1002/art.27584
  7. Nasonov E.L., Avdeeva A.S., Dibrov D.A. Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice 2023;61(3):276–91. (In Russ.). doi: 10.47360/1995-4484-2023-276-291
  8. Novikov A.A., Baranov A.N., Bulanov N.M. et al. Determination of antinuclear antibodies: recommendations of EFLM, EASI, CAP and RAMLD. Meditsinskiy alfavit = Medical Alphabet 2024;(31):21–5. (In Russ.). doi: 10.33667/2078-5631-2024-31-21-25
  9. Chun C., Kingsbury D.J. Poststreptococcal reactive arthritis: diagnostic challenges. Perm J 2019;23:18.304. doi: 10.7812/TPP/18.304
  10. Taniguchi Y., Nishikawa H., Yoshida T. et al. Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA. Rheumatol Int 2021;41(8):1387–98. doi: 10.1007/s00296-021-04879-3
  11. Johnston J.J., Douglas R. Adenotonsillar microbiome: an update. Postgrad Med J 2018;94(1113):398–403. doi: 10.1136/postgradmedj-2018-135602

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 ABV-press

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36931 от  21.07.2009.